Network origin in Janet Lynch Lambert first degree
Entity | Entity type | Industry | |
---|---|---|---|
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field.
31
| Non-Profit Organization | Medical/Nursing Services | 31 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Janet Lynch Lambert via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | General Counsel Public Communications Contact | |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Analyst Private Equity Investor | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
DNIB UNWIND INC | Biotechnology | Director/Board Member | |
SHIRE | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of Virginia | College/University | Undergraduate Degree | |
BLUEBIRD BIO, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
Boston College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Idaho State University | College/University | Graduate Degree | |
Yale University | College/University | Undergraduate Degree Graduate Degree | |
New York University | College/University | Doctorate Degree Doctorate Degree | |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Doctorate Degree | |
University of California, Berkeley | College/University | Doctorate Degree Doctorate Degree | |
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
University College London | College/University | Doctorate Degree Corporate Officer/Principal | |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Investment Managers | Private Equity Investor | |
ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
King's College London | College/University | Graduate Degree Doctorate Degree | |
Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
ALLERGAN PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
UNIQURE N.V. | Biotechnology | Corporate Officer/Principal | |
SYROS PHARMACEUTICALS, INC. | Biotechnology | Corporate Officer/Principal | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
EDITAS MEDICINE, INC. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
JUNO THERAPEUTICS INC | Biotechnology | Corporate Officer/Principal | |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
POSEIDA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Chief Executive Officer Founder Director/Board Member | |
SIGILON THERAPEUTICS, INC. | Biotechnology | Chief Operating Officer | |
STOKE THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Technology Exchange, Inc. | Founder | ||
VOR BIOPHARMA INC. | Biotechnology | Chairman Chief Executive Officer | |
AKOUOS | Biotechnology | Chairman | |
University of Illinois At Urbana–Champaign | College/University | Undergraduate Degree Undergraduate Degree | |
ORCHARD THERAPEUTICS PLC | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Director/Board Member | |
ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
AUTOLUS THERAPEUTICS PLC | Biotechnology | Director/Board Member Chief Operating Officer | |
Orchard Therapeutics North America
Orchard Therapeutics North America BiotechnologyHealth Technology Part of Orchard Therapeutics Plc, Orchard Therapeutics North America provides biotechnology research services. The company is based in Boston, MA. The CEO of the company is Bobby Gaspar. | Biotechnology | President Chief Executive Officer | |
Frankel Group LLC | Corporate Officer/Principal |
Statistics
International
United States | 40 |
United Kingdom | 6 |
Ireland | 3 |
Canada | 2 |
Netherlands | 2 |
Sectoral
Health Technology | 30 |
Consumer Services | 13 |
Finance | 4 |
Commercial Services | 3 |
Operational
Director/Board Member | 144 |
Corporate Officer/Principal | 81 |
Chief Executive Officer | 47 |
President | 34 |
Undergraduate Degree | 24 |
Most connected contacts
Insiders | |
---|---|
Cynthia Collins | 27 |
Alexander Vos | 17 |
Robert Azelby | 15 |
Arthur Tzianabos | 15 |
Maria Fardis | 15 |
Mark Rothera | 14 |
Matt Patterson | 14 |
Derrell Porter | 14 |
Jeffrey Walsh | 14 |
Robert Preti | 14 |
Bradley Campbell | 13 |
Miguel Forte | 12 |
Christopher Mason | 12 |
Joanne Beck | 12 |
Bob Ang | 12 |
- Stock Market
- Insiders
- Janet Lynch Lambert
- Company connections